| [1] |
Zhao Qing, Sun Lele, Ao Suiting, Zhai Yufan, Liu Hong, Zhang Furen.
Analysis of immune dysregulation in drug hypersensitivity by using dapsone hypersensitivity syndrome as a model
[J]. Chinese Journal of Dermatology, 2026, 59(9): 844-849.
|
| [2] |
Chinese Society of Dermatology, Chinese Society of Allergy, China Leprosy Association.
Chinese guideline for the diagnosis and treatment of drug eruptions (2026 edition)
[J]. Chinese Journal of Dermatology, 2026, 59(9): 811-826.
|
| [3] |
Li Yanhong, Jiang Kun, Wu Zhuoxuan, Zhang Jianlan, Fang Meizhen, Liu Shuting, Wang Linlin, Hu Lei, Zhou Xiaoyong, Chen Liuqing, Chen Jinbo.
Analysis of 18 cases of cutaneous adverse reactions associated with programmed death-1 inhibitors
[J]. Chinese Journal of Dermatology, 2026, 59(8): 783-787.
|
| [4] |
Sun Songpeng, Long Junhong, Cao Bo, Xu Yue, Zhang Xiang′an, Cao Hui, Xie Jun, Gui Ping, Sun Xiaojun, Zhang Bo, Xu Zhijie, Li Jin′an, Wang Zhigang, Wu Wei, Yang Huiju, Wei Ping, Liu Congcong, Shen Qingbo, Yu Fan, Chu Hongchuan, Zhou Yangyang, Liu Jiaxin, Liu Yan, Huo Xingxiao, Chen Hang, Jing Tao, Gao Jing, Wang Yanxun, Wang Rui, Li Zhenyu, Zhang Shuxin.
Efficacy and safety of Fuzhiqing ointment versus triamcinolone acetonide and econazole nitrate cream in the treatment of chronic perianal eczema: a multicenter, randomized, double-blind, controlled, equivalence trial
[J]. Chinese Journal of Dermatology, 2026, 59(6): 564-570.
|
| [5] |
Wu Bo, Chen Xing, Chai Yuanyuan, Cao Rong, Chen Qian, Zhu Hongyan.
Correlation analysis between serum vitamin D levels and macrophage inflammation in children with atopic dermatitis of different severity
[J]. Chinese Journal of Dermatology, 2026, 59(6): 547-552.
|
| [6] |
Zhang Xiaoxu, Luo Suju.
Efficacy and safety of upadacitinib in the treatment of six cases of palmoplantar pustulosis
[J]. Chinese Journal of Dermatology, 2026, 59(5): 459-463.
|
| [7] |
Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment, Patient Education Expert Committee, Chinese Society of Clinical Oncology .
Chinese expert consensus on multidisciplinary management of cancer treatment-related cutaneous adverse events (2026 edition)
[J]. Chinese Journal of Dermatology, 2026, 59(4): 304-319.
|
| [8] |
Luo Fei, Shi Yueyu, Xiao Peng, Di Linjin, Luo Shengqun, Zhang Xinjiang, Liu Zhiyong, Zhou Shuang.
Comparison of efficacy of 2-year versus 1-year multidrug therapy for leprosy patients in Chongqing, 2007-2020
[J]. Chinese Journal of Dermatology, 2026, 59(3): 237-243.
|
| [9] |
Li Zifan¹, Yu Ruoxi¹, Lin Ying².
Dupilumab?associated head and neck dermatitis
[J]. Chinese Journal of Dermatology, 2026, 0(3): 20250040-e20250040.
|
| [10] |
Wang Caixia, Xu Fan, Shi Jing, Zhu Hailian, Lu Guiling, Wang Hongmei.
Efficacy and safety of omalizumab and dupilumab for the treatment of bullous pemphigoid: a systematic review
[J]. Chinese Journal of Dermatology, 2026, 59(3): 262-268.
|
| [11] |
Xu Guokang, Cai Mei.
Sonidegib in the treatment of locally advanced basal cell carcinoma: a clinical analysis of eight cases
[J]. Chinese Journal of Dermatology, 2026, 59(2): 166-169.
|
| [12] |
Qiu Li, Xiao Ting .
Bruton′s tyrosine kinase inhibitors in the treatment of chronic spontaneous urticaria
[J]. Chinese Journal of Dermatology, 2025, 58(6): 563-567.
|
| [13] |
Wan Yongjun, Yang Haijing, Yan Qiao, Chen Mei, Wang Fengyuan, Su Qianya, Dong Zhengbang, Wang Fei.
Clinical and prognostic analysis of nine cases of immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis
[J]. Chinese Journal of Dermatology, 2025, 58(4): 347-351.
|
| [14] |
Mu Kui, Guo Hui, Wen Haiquan, Long Hai, Liu Yu, Luo Shuaihantian, Huang Xin, Zhou Xingyu, Xiao Rong, Li Yaping.
Efficacy and safety analysis of combined telitacicept in 25 patients with systemic lupus erythematosus based on standard therapy
[J]. Chinese Journal of Dermatology, 2025, 58(4): 322-327.
|
| [15] |
Pi Jiangshan, Chen Jingsi, Wang Lingling, Shen Zhanting, Luo Xiaoyan, Wang Hua.
Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis in infants aged 6 months to 2 years: a prospective, single-center clinical trial
[J]. Chinese Journal of Dermatology, 2025, 58(10): 930-935.
|